TYGACIL Side Effects

7023035-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatitis Cholestatic, Jaundice Cholestatic
on Sep 23, 2010 Male patient from GREECE , 80 years of age, was diagnosed with diabetic foot, femoral artery occlusion and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatitis cholestatic, jaundice cholestatic. Tygacil dosage: . During the same period patient was treated with NEOMYCIN (View Neomycin Review and Neomycin Label ), PANWARFIN (View Panwarfin Review and Panwarfin Label ), PANTOZOL CONTROL (View Pantozol Control Review and Pantozol Control Label ), LOFTYL (View Loftyl Review and Loftyl Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ). Patient was hospitalized.

7010542-0 | Coagulopathy, Condition Aggravated, Hypoglycaemia
Patient was taking Tygacil (View Usage). Patient had the following side effects: coagulopathy, condition aggravated, hypoglycaemia on Sep 17, 2010 from SPAIN Additional patient health information: Male patient , 40 years of age, was diagnosed with respiratory tract infection, fungal infection (What is fungal infection?) and. Tygacil dosage: . During the same period patient was treated with CLEXANE (View Clexane Review and Clexane Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), VFEND (View Vfend Review and Vfend Label ), SANDIMMUNE (From 125 To 220 Mg Every 12 Hours) (View Sandimmune Review and Sandimmune Label ).

7005995-8 | Disease Progression, Pathogen Resistance
Adverse event was reported on Sep 09, 2010 by a Male patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with pneumonia klebsiella, pneumonia staphylococcal, candidiasis, enterococcal infection and. Location: POLAND , 43 years of age, After Tygacil was administered, patient had the following side effects: disease progression, pathogen resistance. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), UNASYN (View Unasyn Review and Unasyn Label ).

7005994-6 | Disease Progression, Pathogen Resistance
on Sep 09, 2010 Male patient from POLAND , 41 years of age, was diagnosed with pseudomonas infection, stenotrophomonas infection, escherichia infection, enterococcal infection, candidiasis and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, pathogen resistance. Tygacil dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ZYVOX (View Zyvox Review and Zyvox Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), BISEPTOL (View Biseptol Review and Biseptol Label ).


7003488-5 | Alanine Aminotransferase Increased, Bilirubin Conjugated Increased, Condition Aggravated, Gamma-glutamyltransferase Increased, Ileus, Oedematous Pancreatitis
on Sep 13, 2010 Male patient from FRANCE , weighting 55.12 lb, was diagnosed with osteomyelitis bacterial, enterobacter infection, sepsis syndrome and was treated with Tygacil (View Usage). Patient had the following side effects: alanine aminotransferase increased, bilirubin conjugated increased, condition aggravated, gamma-glutamyltransferase increased, ileus, oedematous pancreatitis. Tygacil dosage: 100 Mg Loading Dose Then 50 Mg 1 Per 12 Hours. During the same period patient was treated with PRIMAXIN (View Primaxin Review and Primaxin Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), CIFLOX (View Ciflox Review and Ciflox Label ), COLIMYCINE (3.75 Miu Total Daily) (View Colimycine Review and Colimycine Label ). Patient was hospitalized.

6994560-4 | Chest Pain, Infusion Related Reaction
Patient was taking Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: chest pain (What is chest pain?), infusion related reaction on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 43 years of age, weighting 211.6 lb, was diagnosed with staphylococcal bacteraemia and. Tygacil dosage: 100mg Every 24 Hrs Iv Drip (ordered Thru August 6). Patient was hospitalized.

6984121-5 | Abdominal Pain Upper, Back Pain
Adverse event was reported on May 29, 2009 by a Female patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with stenotrophomonas infection and. Location: UNITED STATES , weighting 245.2 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, back pain (What is back pain?). During the same period patient was treated with ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CLAVULANIC ACID/TICARCILLIN DISODIUM (View Clavulanic Acid/ticarcillin Disodium Review and Clavulanic Acid/ticarcillin Disodium Label ).

6983972-0 | Hypoaesthesia, Paraesthesia
on Apr 17, 2009 Female patient from UNITED STATES , 83 years of age, was diagnosed with infection (What is infection?) and was treated with Tygacil (View Usage). Patient had the following side effects: hypoaesthesia, paraesthesia. Tygacil dosage: . During the same period patient was treated with CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ).

6983932-X | Pancreatitis
on May 19, 2009 Female patient from UNITED STATES , weighting 102.3 lb, was diagnosed with sepsis (What is sepsis?) and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: pancreatitis. Tygacil dosage: . During the same period patient was treated with VANCOMYCIN (250 Mg/5 Ml Every 6 Hours) (View Vancomycin Review and Vancomycin Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), INSULIN GLARGINE (5 Unit Every 1 Day) (View Insulin Glargine Review and Insulin Glargine Label ), INSULIN ASPART (Sliding Scale) (View Insulin Aspart Review and Insulin Aspart Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6983870-2 | Diarrhoea, Hepatic Enzyme Increased, Hypertension
Patient was taking Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hepatic enzyme increased, hypertension on May 26, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 140.1 lb, was diagnosed with abscess (What is abscess?) and. Tygacil dosage: .

6983857-X | Hepatic Failure
Adverse event was reported on Mar 19, 2009 by a Male patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with cellulitis (What is cellulitis?) and. Location: UNITED STATES , 59 years of age, weighting 220.2 lb, Patient had the following side effects: hepatic failure. During the same period patient was treated with LIPIDS NOS (View Lipids Nos Review and Lipids Nos Label ), TPN ELECTROLYTES IN PLASTIC CONTAINER (View Tpn Electrolytes In Plastic Container Review and Tpn Electrolytes In Plastic Container Label ), NEXIUM (View Nexium Review and Nexium Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

6983817-9 | Pancreatitis
on Jan 22, 2009 Female patient from UNITED STATES , weighting 88.18 lb, was diagnosed with pyrexia and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: pancreatitis. Tygacil dosage: . During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), ZOCOR (View Zocor Review and Zocor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VASOTEC (View Vasotec Review and Vasotec Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), BENADRYL (View Benadryl Review and Benadryl Label ), CATAPRES (View Catapres Review and Catapres Label ), COMBIVENT (View Combivent Review and Combivent Label ). Patient was hospitalized.

6983802-7 | Pancreatitis
on Jan 09, 2009 Male patient from UNITED STATES , child 6 years of age, weighting 44.09 lb, was diagnosed with lupus nephritis and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Tygacil dosage: 1.5 Mg/kg Followed By 1mg/kg Every 12 Hours. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

6983747-2 | Thrombocytopenia
Patient was taking Tygacil (View Usage). Patient had the following side effects: thrombocytopenia on Dec 11, 2008 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 224.9 lb, was diagnosed with cellulitis (What is cellulitis?) and. Tygacil dosage: .

6983742-3 | Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased
Adverse event was reported on Dec 11, 2008 by a Female patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with oesophageal carcinoma and. Location: UNITED STATES , 74 years of age, After Tygacil was administered, patient had the following side effects: blood alkaline phosphatase increased, blood bilirubin increased.

6983669-7 | Infusion Site Pain
on Jan 28, 2009 Female patient from UNITED STATES , weighting 188.5 lb, was diagnosed with pyrexia and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: infusion site pain. Tygacil dosage: .

6983620-X | Erythema, Gastrointestinal Stoma Complication, Infection
on Sep 02, 2008 Female patient from UNITED STATES , 27 years of age, was treated with Tygacil (View Usage). Patient had the following side effects: erythema, gastrointestinal stoma complication, infection (What is infection?). Tygacil dosage: 100 Mg Loading Dose, Then 50 Mg Every 12 Hours.

6983604-1 | Diarrhoea, Nausea
Patient was taking Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: diarrhoea, nausea (What is nausea?) on Oct 08, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 170.4 lb, was diagnosed with arthritis bacterial and. Tygacil dosage: 50 Mg Every 12 Hours. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), COLACE (View Colace Review and Colace Label ), ULTRAM (50 Mg Tablet (1-2), Every 4 Hours As Needed) (View Ultram Review and Ultram Label ), ALBUTEROL (0.83 Mg/ml Every 4 Hours) (View Albuterol Review and Albuterol Label ), RESTORIL (15 Mg (1-2) Every Night As Needed) (View Restoril Review and Restoril Label ).

6983598-9 | Pancreatitis
Adverse event was reported on Oct 02, 2008 by a Male patient taking Tygacil (View Usage) (Dosage: 50 Mg/ml Every 12 Hours) was diagnosed with lung infection, mycobacterium chelonei infection, mycobacterium abscessus infection and. Location: UNITED STATES , weighting 196.2 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis. During the same period patient was treated with AMIKACIN (750 Mg Daily) (View Amikacin Review and Amikacin Label ). Patient was hospitalized.

6983576-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Platelet Count Decreased
on Sep 29, 2008 Male patient from UNITED STATES , weighting 149.9 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and was treated with Tygacil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, platelet count decreased. Tygacil dosage: . During the same period patient was treated with ZYVOX (Daily) (View Zyvox Review and Zyvox Label ).

6983575-8 | Heparin-induced Thrombocytopenia
on Oct 07, 2008 Female patient from UNITED STATES , 43 years of age, weighting 149.9 lb, was diagnosed with breast abscess, escherichia bacteraemia, klebsiella bacteraemia and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: heparin-induced thrombocytopenia. Tygacil dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6983566-7 | Burning Sensation, Paraesthesia
Patient was taking Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, paraesthesia on Aug 08, 2008 from UNITED STATES Additional patient health information: Male patient , 43 years of age, weighting 191.2 lb, was diagnosed with diverticulitis, pelvic abscess and. Tygacil dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), BENADRYL (View Benadryl Review and Benadryl Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ).

6983559-X | Platelet Count Decreased
Adverse event was reported on Oct 14, 2008 by a Female patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with abdominal infection and. Location: UNITED STATES , weighting 107.8 lb, Patient had the following side effects: platelet count decreased. During the same period patient was treated with POTASSIUM (View Potassium Review and Potassium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), IMDUR (View Imdur Review and Imdur Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LORCET HD (View Lorcet-hd Review and Lorcet-hd Label ), KLONOPIN (Unknwon) (View Klonopin Review and Klonopin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ).

6983551-5 | Pancreatitis Acute
on Aug 18, 2008 Male patient from UNITED STATES , weighting 158.3 lb, was diagnosed with mycobacterium abscessus infection and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: pancreatitis acute. Tygacil dosage: . During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), ZYVOX (View Zyvox Review and Zyvox Label ). Patient was hospitalized.

6983524-2 | Deafness
on Jul 29, 2008 Female patient from UNITED STATES , 82 years of age, was diagnosed with skin infection and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: deafness. Tygacil dosage: .

6983507-2 | Thrombocytopenia
Patient was taking Tygacil (View Usage). Patient had the following side effects: thrombocytopenia on Jul 02, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 155.2 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?), thyroid disorder and. Tygacil dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), LOPID (View Lopid Review and Lopid Label ), AVAPRO (View Avapro Review and Avapro Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), ALPRAZOLAM (.5 Mg Every 1 Prn) (View Alprazolam Review and Alprazolam Label ), MECLOZINE (View Meclozine Review and Meclozine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), METHOCARBAMOL (View Methocarbamol Review and Methocarbamol Label ).

6983486-8 | Pancreatitis
Adverse event was reported on Aug 27, 2008 by a Female patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with colitis, anxiety (What is anxiety?) and. Location: UNITED STATES , 71 years of age, weighting 359.3 lb, After Tygacil was administered, patient had the following side effects: pancreatitis. During the same period patient was treated with BUMEX (View Bumex Review and Bumex Label ), ALPRAZOLAM (0.25 Mg Q6hr Prn) (View Alprazolam Review and Alprazolam Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FENTANYL CITRATE (25 Mcg Patch-q3days) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6960517-2 | Coagulopathy, Condition Aggravated, Hypoglycaemia
on Aug 26, 2010 Male patient from SPAIN , 40 years of age, was diagnosed with respiratory tract infection, fungal infection (What is fungal infection?) and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, condition aggravated, hypoglycaemia. Tygacil dosage: . During the same period patient was treated with CLEXANE (View Clexane Review and Clexane Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), VFEND (View Vfend Review and Vfend Label ), SANDIMMUNE (From 125 To 220 Mg Every 12 Hours) (View Sandimmune Review and Sandimmune Label ).

6936065-2 | Hyperhidrosis, Hypoaesthesia, Hypotension, Nausea, Paraesthesia
on Jun 16, 2009 Female patient from UNITED STATES , 83 years of age, weighting 86.07 lb, was diagnosed with infection (What is infection?) and was treated with Tygacil (View Usage). Patient had the following side effects: hyperhidrosis, hypoaesthesia, hypotension, nausea (What is nausea?), paraesthesia. Tygacil dosage: 50 Mg 1x Per 12 Hr, Intravenous. During the same period patient was treated with AZTREONAM (AZTREONAM) (View Aztreonam (aztreonam) Review and Aztreonam (aztreonam) Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ).

6936062-7 | Nausea, Pancreatitis
Patient was taking Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: nausea (What is nausea?), pancreatitis on Oct 12, 2009 from UNITED STATES Additional patient health information: Male patient , 47 years of age, was diagnosed with lyme disease and. Tygacil dosage: Intraveneous. During the same period patient was treated with ZETIA (View Zetia Review and Zetia Label ). Patient was hospitalized.

6936059-7 | Hepatic Failure
Adverse event was reported on Sep 11, 2009 by a Female patient taking Tygacil (View Usage) (Dosage: Normal) . Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: hepatic failure. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), ACIDOPHILUS ^ZYMA^ (LACTOBACILLUS ACIDOPHILUS) (View Acidophilus ^zyma^ (lactobacillus Acidophilus) Review and Acidophilus ^zyma^ (lactobacillus Acidophilus) Label ).

6936056-1 | Pancreatitis
on Sep 04, 2009 Female patient from UNITED STATES , 66 years of age, weighting 145.5 lb, was diagnosed with helicobacter infection and was treated with Tygacil (View Usage). Patient had the following side effects: pancreatitis. Tygacil dosage: 50 Mg 1x Per 12 Hr, Intravenous. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6936035-4 | Blood Thromboplastin, Blood Urea, Blood Urea Increased, International Normalised Ratio Increased
on Aug 05, 2009 Male patient from UNITED STATES , 67 years of age, weighting 210.8 lb, was diagnosed with osteomyelitis and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: blood thromboplastin, blood urea, blood urea increased, international normalised ratio increased. Tygacil dosage: 50 Mg 1x Per 12 Hr, Intravenous. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TUMS (CALCIUM CARBONATE/MAGNESIUM CARBONATE/ MAGNESIUM TRISILICATE) (View Tums (calcium Carbonate/magnesium Carbonate/ Magnesium Trisilicate) Review and Tums (calcium Carbonate/magnesium Carbonate/ Magnesium Trisilicate) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PLAVIX (View Plavix Review and Plavix Label ), DOCUSATE (DOCUSATE) (View Docusate (docusate) Review and Docusate (docusate) Label ), LOVENOX (View Lovenox Review and Lovenox Label ), LASIX (View Lasix Review and Lasix Label ).

6936032-9 | Blood Urea Increased
Patient was taking Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: blood urea increased on Aug 05, 2009 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 145.5 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Tygacil dosage: 50 Mg 1x Per 12 Hr, Intravenous. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), PROTONIX (View Protonix Review and Protonix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LOVENOX (View Lovenox Review and Lovenox Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6936030-5 | Pancreatitis
Adverse event was reported on Jul 27, 2009 by a Female patient taking Tygacil (View Usage) (Dosage: Intravenous) . Location: UNITED STATES , 23 years of age, weighting 133.1 lb, Patient had the following side effects: pancreatitis. During the same period patient was treated with FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

6936018-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Jul 20, 2009 Female patient from UNITED STATES , 82 years of age, weighting 109.6 lb, was diagnosed with lung infection, staphylococcal infection (What is staphylococcal infection?) and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Tygacil dosage: 50 Mg 1x Per 12 Hr, Intravenous. Patient was hospitalized.

6935985-2 | Thrombocytopenia
on Jun 25, 2009 Male patient from UNITED STATES , 84 years of age, was diagnosed with cellulitis (What is cellulitis?) and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Tygacil dosage: 100 Mg Then 50 Mg Q 12 H, Intravenous. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), PROTONIX (View Protonix Review and Protonix Label ).

6935969-4 | Infection
Patient was taking Tygacil (View Usage). Patient had the following side effects: infection (What is infection?) on Mar 30, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, was diagnosed with infection (What is infection?) and. Tygacil dosage: 100 Mg, Intravenous. During the same period patient was treated with MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ).

6935940-2 | Pancreatitis
Adverse event was reported on Feb 08, 2010 by a Female patient taking Tygacil (View Usage) (Dosage: 50 Mg 1x Per 12 Hr Intravenous) was diagnosed with osteomyelitis and. Location: UNITED STATES , 61 years of age, weighting 174.2 lb, After Tygacil was administered, patient had the following side effects: pancreatitis. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), PLAVIX (View Plavix Review and Plavix Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6935936-0 | Hypotension, Nausea, Tachycardia
on May 19, 2010 Male patient from UNITED STATES , 24 years of age, weighting 308.6 lb, was diagnosed with open fracture, staphylococcal infection (What is staphylococcal infection?) and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, nausea (What is nausea?), tachycardia. Tygacil dosage: . During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ).

6935900-1 | Mental Status Changes
on Sep 01, 2009 Female patient from UNITED STATES , 52 years of age, weighting 160.1 lb, was treated with Tygacil (View Usage). Patient had the following side effects: mental status changes. Tygacil dosage: 50 Mg 2x Per 1 Day Intravenous. During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), XOPENEX (View Xopenex Review and Xopenex Label ), AVALIDE (View Avalide Review and Avalide Label ), NEXIUM (View Nexium Review and Nexium Label ), LORATADINE (View Loratadine Review and Loratadine Label ).

6935652-5 | Cardiac Arrest, Epidermolysis, Rash Maculo-papular, Rash Pustular, Skin Hyperpigmentation, Skin Reaction
Patient was taking Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), epidermolysis, rash maculo-papular, rash pustular, skin hyperpigmentation, skin reaction on Aug 18, 2010 from GREECE Additional patient health information: Female patient , 74 years of age, weighting 143.3 lb, was diagnosed with klebsiella bacteraemia and. Tygacil dosage: . During the same period patient was treated with NEXIUM (One Tablet Daily) (View Nexium Review and Nexium Label ), GLOPIR (View Glopir Review and Glopir Label ), PREZOLON (View Prezolon Review and Prezolon Label ), CAPOTEN (View Capoten Review and Capoten Label ), DILATREND (View Dilatrend Review and Dilatrend Label ), GARAMYCIN (View Garamycin Review and Garamycin Label ), CLEXANE (View Clexane Review and Clexane Label ). Patient was hospitalized.

6927910-5 | Chest Pain, Hyperhidrosis, Nausea
Adverse event was reported on Aug 10, 2010 by a Male patient taking Tygacil (View Usage) (Dosage: 55 Mg (out Of 100mg Bag)) was diagnosed with wound (What is wound?) and. Location: UNITED STATES , weighting 265.9 lb, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), hyperhidrosis, nausea (What is nausea?). During the same period patient was treated with ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), DIAZEPAM (5mg/10mg Once Daily) (View Diazepam Review and Diazepam Label ), BENADRYL (View Benadryl Review and Benadryl Label ), TEMAZEPAM (30 Mg Q Hs Prn) (View Temazepam Review and Temazepam Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (5/325 Mg Qid) (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), NITROGLYCERIN (0.4 Mg Prn) (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

6917717-7 | Haemolytic Anaemia
on Aug 04, 2010 Male patient from UNITED KINGDOM , 55 years of age, was diagnosed with klebsiella infection and was treated with Tygacil (View Usage). Patient had the following side effects: haemolytic anaemia. Tygacil dosage: . During the same period patient was treated with PENICILLIN G (View Penicillin G Review and Penicillin G Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), COLISTIN (View Colistin Review and Colistin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6915133-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Jaundice Cholestatic
on Aug 02, 2010 Male patient from GREECE , 80 years of age, was diagnosed with diabetic foot and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, jaundice cholestatic. Tygacil dosage: . During the same period patient was treated with NEOMYCIN (View Neomycin Review and Neomycin Label ), PANWARFIN (View Panwarfin Review and Panwarfin Label ), PANTOZOL CONTROL (View Pantozol Control Review and Pantozol Control Label ), LOFTYL (View Loftyl Review and Loftyl Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ). Patient was hospitalized.

6901299-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Jaundice Cholestatic
Patient was taking Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, jaundice cholestatic on Jul 27, 2010 from GREECE Additional patient health information: Male patient , 80 years of age, was diagnosed with diabetic foot and. Tygacil dosage: . During the same period patient was treated with NEOMYCIN (View Neomycin Review and Neomycin Label ), PANWARFIN (View Panwarfin Review and Panwarfin Label ), PANTOZOL CONTROL (View Pantozol Control Review and Pantozol Control Label ), LOFTYL (View Loftyl Review and Loftyl Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ). Patient was hospitalized.

6883950-6 | High Density Lipoprotein Decreased, Hypocholesterolaemia, Low Density Lipoprotein Decreased
Adverse event was reported on Jul 26, 2010 by a Male patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with cellulitis (What is cellulitis?) and. Location: SERBIA , weighting 216.1 lb, Patient had the following side effects: high density lipoprotein decreased, hypocholesterolaemia, low density lipoprotein decreased. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ).

6883519-3 | Cerebrovascular Accident, Metal Poisoning
on Jul 19, 2010 Male patient from HONDURAS , 54 years of age, was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: cerebrovascular accident, metal poisoning. Tygacil dosage: .

6881837-6 | Platelet Count Decreased
on Jul 15, 2010 Male patient from UNITED STATES , 88 years of age, weighting 141.1 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Tygacil dosage: 100 Mg Loading Dose, Then 50 Mg Q12h. During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PROCRIT (View Procrit Review and Procrit Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), MORPHINE (View Morphine Review and Morphine Label ), ZOFRAN (View Zofran Review and Zofran Label ), PROTONIX (View Protonix Review and Protonix Label ).

6879450-X | Hepatitis Toxic, Jaundice
Patient was taking Tygacil (View Usage). Patient had the following side effects: hepatitis toxic, jaundice (What is jaundice?) on Jul 23, 2010 from BELGIUM Additional patient health information: Female patient , 87 years of age, was diagnosed with erysipelas, hypertension, angina pectoris, hypercholesterolaemia and. Tygacil dosage: 50 Mg Twice Daily For 1 Day, Followed By 50 Mg Per Day Subsequently. During the same period patient was treated with AMLOR (View Amlor Review and Amlor Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ZOCOR (View Zocor Review and Zocor Label ), ASAFLOW (View Asaflow Review and Asaflow Label ), PLAVIX (View Plavix Review and Plavix Label ), EMCONCOR (View Emconcor Review and Emconcor Label ). Patient was hospitalized.